BioXcel Therapeutics, Inc. - COM (BTAI)

Historical Portfolio Holders from Q1 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
8.99 M
Holdings value Q1 2024
$25.4 M
Value change Q1 2024
-$488 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
66
Number of buys Q1 2024
27
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
09075P105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 8.99 M $25.4 M -$488 K $2.82 66
2023 Q4 9.13 M $26.9 M -$1.87 M $2.95 67
2023 Q3 10.1 M $25.4 M -$27.9 M $2.53 77
2023 Q2 17.6 M $117 M -$7.22 M $6.66 85
2023 Q1 17.2 M $322 M +$70.4 M $18.66 93
2022 Q4 13.4 M $288 M +$37.8 M $21.48 77
2022 Q3 10.3 M $122 M -$12.2 M $11.82 74
2022 Q2 11.2 M $147 M -$10.4 M $13.20 84
2022 Q1 13 M $272 M -$16.4 M $20.91 88
2021 Q4 13.6 M $277 M +$19.4 M $20.33 85
2021 Q3 8.96 M $272 M -$29.4 M $30.35 97
2021 Q2 13 M $378 M +$41.2 M $29.06 104
2021 Q1 11 M $474 M -$55.2 M $43.16 111
2020 Q4 12.2 M $562 M +$17.6 M $46.20 109
2020 Q3 9.93 M $430 M +$75.9 M $43.36 99
2020 Q2 8.11 M $430 M +$117 M $53.01 99
2020 Q1 5.49 M $123 M +$37.5 M $22.35 64
2019 Q4 4.33 M $63 M +$1.37 M $14.61 40
2019 Q3 4.18 M $29.4 M +$8.27 M $7.04 40
2019 Q2 2.93 M $32 M +$4.62 M $10.96 32
2019 Q1 2.51 M $24.9 M +$932 K $9.89 19
2018 Q4 2.42 M $9.35 M -$3.41 M $3.85 11
2018 Q3 3.25 M $25 M -$3.83 M $7.66 16
2018 Q2 3.72 M $34.2 M -$9.79 M $9.20 18
2018 Q1 4.68 M $47.8 M +$47.8 M $10.24 21